AzTrials
AzTrials

CariesMiswakNCT02418520

The Effect of Miswak Chewing Sticks on the Oral Helicobacter Pylori Infection

A study testing Miswak in people with Caries and Periodontitis, run by Kuwait University at 1 site in Kuwait.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To elucidate the relationship of chewing miswak sticks on the H. Pylori infection in the oral cavity.The study would be conducted at the Faculty of Dentistry, Kuwait University. Oral plaque samples would be obtained from those patients who are willing to participate. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Caries, Periodontitis
What is being tested?
Miswak
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteKuwait
Study dates
1 Oct 2019to 1 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Subjects aged > 18yrs
  • Having >24 teeth
  • Physically/mentally healthy

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country.

Kuwait1 site
  • Kuwait University, faculty of dentistry

    Kuwait City, 13110

Other trials in Kuwait

About this study

To elucidate the relationship of chewing miswak sticks on the H. Pylori infection in the oral cavity.The study would be conducted at the Faculty of Dentistry, Kuwait University.

Oral plaque samples would be obtained from those patients who are willing to participate. As a part of the initial screening the plaque samples would be collected and sent for screening of oral microbiota to the Microbiology Department of Faculty of Dentistry, Kuwait University. Here, the basic microbial culturing (rapid urease test) would be performed for detecting the presence of oral H.Pylori. Volunteers who are tested positive for H. Pylori infection through the rapid urease test would be invited to participate in the study.

Read the detailed description

Ethical aspects The experimental protocol was approved by the Health Science Center (HSC) ethical committee of Kuwait University (VDR/ED/3331) and is registered at ClinicalTrials.gov as NCT02418520 (16/04/2015). Research was conducted according to the principles outlined in the declaration of Helsinki on human medical experimentation. Written informed consent was obtained from all participants and is presented in accordance to the consolidated standards of reporting trials (CONSORT) guidelines.

Study Design This was an experimental study with a randomized, cross-over, single blind design.

Study sample and Data collection This study was conducted among regular patients attending the Dental Center at Kuwait University, Kuwait. Patient recruitment started in February and was completed by the end of August 2019. The PICO (P = Patient population; I = Intervention of interest; C = Comparative intervention; O = Outcome) question for this study was, "for subjects under different fasting conditions (P), what is the effect of using miswak chewing sticks along with toothbrush (I) versus using only toothbrush (C) on the oral H. pylori counts (O)?". Volunteering patients were briefed on the study components and informed consent was obtained from them. Salivary and plaque samples were collected for PCR screening to detect the presence of H. pylori. The inclusion criteria were: 1) subjects with detectable levels of H. pylori in either plaque or salivary samples; 2) no evidence of periodontitis; and, 3) with at least 24 teeth. Subjects who received antibiotic therapy or proton-pump inhibitors within the past three months were excluded from the study.

Recruitment of study participants and grouping This study included 20 subjects who were on 12-hour fasting (fasting group) and 20 subjects who were not fasting (non-fasting group). Non-fasting group subjects were recruited between February and April and fasting group subjects were recruited between May and June 2018 (holy month of Ramadan). At baseline (T0), each subject was assigned numbers based on the chronological order of enrolment in the study. Both, the fasting and the non-fasting subjects were randomly subdivided into Group-1 and Group-2 (n=10 each). Randomized assignment of the subjects was carried out by a random binary outcome of a dice, even or odd numbers. The examiners were kept unaware of the participant allocation. Group-1 subjects were instructed to use both toothbrush and miswak (TB+M) for two weeks (T1) and only toothbrush (TB) for the next two weeks (T2); and, Group-2 subjects were asked to use only TB during T1 and TB+M during T2, for both the fasting and the non-fasting groups. Participants were given instructions on how to use miswak (five finger-grip, scrub technique, for 15 mins, twice daily21) and TB (modified Bass technique, for two minutes, twice daily) by a single investigator (JKB). Plaque and salivary samples were collected at T0, T1 and T2.

Questionnaire The subjects were interviewed and information were collected on their socio-demographic characteristics (age, gender, education, employment and income), presence of selected medical conditions (hypertension, diabetes and current medications), smoking status and dental characteristics (daily brushing frequency and previous dental visit).

Clinical Examination At baseline (T0), three trained and calibrated examiners performed the clinical examinations using a mouth mirror and a manual periodontal probe (CP11 Hu Friedy, Europe), with the patient in semi-supine position on the dental chair (A-dec, Newberg, OR, USA). The clinical examinations assessed the Silness \& Löe plaque index (PI), the Löe \& Silness gingival index (GI), the clinical attachment loss (CAL), the probing depth (PD) and the bleeding on probing (BOP) (inter/intra examiner reliability >80%). These measurements were performed on six surfaces (midlingual/palatal, distolingual/palatal, mesiolingual/palatal, distobuccal, midbuccal, and mesiobuccal) of all teeth. Number of missing teeth were recorded.

Sample collection procedure Plaque and salivary samples were collected from the subjects at T0, T1 and T2. Plaque samples were taken from gingival crevice at deepest pocket reading and removed from the clinical site using a sterile universal curette. The sampling area were isolated using salivary ejectors and gently dried by air. The tip of the curette was inserted into the depths of crevice/pocket, moved coronally while in contact with the tooth surface, to remove both sub and supragingival plaque. The samples were then immersed in 0.5 ml sterile distilled water in Eppendorf tubes (epTIPS Standard, Eppendorf AG, Hamburg, Germany). For the collection of stimulated salivary samples, subjects were requested to chew on paraffin wax and expectorated into a plastic funnel connected to a graded measuring cylinder. About 3 ml of saliva was collected from each subject. Immediately after collection, the sample tubes were placed in a container filled with crushed ice and transported to the Oral Microbiology lab for preserving at -800C.

Bacterial culture H. pylori JA1 strain was obtained from the Faculty of Medicine, KUWAIT University. The bacterial strain was grown on trypticase soy agar supplemented with defibrinated sheep blood (5%) at 37 degree Celsius in microaerophilic conditions.

DNA purification Saliva and plaque samples were brought to the laboratory on ice. After vortexing for 1 minute at 12000 × g, the supernatant was removed, and the pellets were stored at -80°C. DNA from the pellets was purified by using a DNeasy DNA purification Kit (Qiagen, Germany) according to manufacturer's instructions. Briefly, the pellets were treated with lysis buffer and proteinase-K at 56 degree Celsius for 1 h. DNA from lysed samples were applied onto a spin column and washed. Purified DNA was eluted using nuclease free water and the DNA concentrations were measured by UV spectrophotometry method using NanoDropTM 1000. Genomic DNA from H. pylori JA1 was purified by using the same method.

Quantitative real-time polymerase chain reaction (qPCR) After purifying the DNA from the samples, the quantities of H. pylori were measured by SYBR Green quantitative real-time PCR method using H. pylori species-specific primers for ureA gene: ureA-F: 5'-CGTGGCAAGCATGATCCAT-3' and ureA-R: 5'- GGGTATGCACGGTTACGAGTTT-3' 44. The qPCR reaction mixture (25 µl) contained 12.5 µl SYBR Green master mix (Power SYBR Green® Kit, Applied Biosystems), 1.0 µl each of forward and reverse primer (0.4 µM), 5.0 µl DNA template and 5.5 µl H2O. The thermal profile was as follows: an initial denaturation at 95°C for 10min, 40 cycles of 95°C for 15-30s, 55 °C for 30s and 72 °C for 30s. Fluorescent signal acquisition was set at the elongation step of each cycle. All qPCR reactions were run on ABpplied Biosystems® Fast 7500 Real-Time PCR machine. Sequence Detection Systems (SDS) (software version 2.3) was used for data analysis. Serially diluted genomic DNA from H. pylori JA1 was used the reactions for plotting the Ct values against deduced bacterial cell concentration (cells/mL) for each species and to construct standard curves using the above software. All the measurements were taken in triplicate for samples, standards and controls.

Data management and statistical analysis A reduction in the H. pylori count using either TB+M or TB under different fasting conditions was the primary outcome of interest in this study. As no a priori information on the effect of miswak on H. pylori was available, the sample size was calculated to detect a 50% difference between groups, assuming a mean 30% reduction in H. pylori counts between the groups, with a standard deviation of 15%. To obtain a power of 80% and for a risk alpha of 0.05, 17 patients per group were required, which was rounded-off to 20, to account for any potential dropouts. The difference in the microbial counts were computed between T0, T1 and T2. Mann-Whitney U-test or Kruskal-Wallis test (continuous dependent variable) and chi-square test (categorical dependent variable) were used to assess the differences in the general characteristics between the two groups. Distribution of H. pylori between the groups were explored for normality using the Kolmogorov-Smirnov and Shapiro-Wilk tests. The data was not normally distributed, so the intragroup change in H. pylori counts was evaluated with the Wilcoxon signed rank test and the intergroup comparisons were made using the Mann-Whitney U-test. Spearman's test was used to assess the correlation between the H. pylori counts (1x103cells/mL) in plaque/salivary samples and the clinical periodontal parameters at baseline. The level of significance was set to p<0.05. All statistical analyses were carried out using SPSS 26.0 (IBM Corp., Armonk, NY, USA).

Being tested
Miswak
Medical subject headings
Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MiswakDevice

    Oral hygiene with Miswak chewing sticks and normal tooth brush

Study groups in NCT02418520
Study groupRoleWhat they receive
Miswak chewingExperimentalChewing Sticks
Receives: Device: Miswak
H.PyloriNo interventionOral H.Pylori

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The main outcome measure would be the change over time of the microbiologic data, specifically the H.Pylori counts within both groups.

    The main outcome variable would be the change over time of the microbiologic data within both groups. Thus, the change in the number H.Pylori would be compared between the two groups at regular predetermined intervals.The patients would be recalled regularly and their plaque samples would be collected and sent for 16SrRNA gene sequencing. Gene sequencing has been known to provide more accurate information on the species of Helicobacter when compared to other methods.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Apr 2015 (estimated)
  2. Study start1 Oct 2019
  3. Primary completion1 Dec 2019
  4. Study completion1 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Model description
Intervention group would use Miswak chewing sticks along with the regular use of tooth brush and paste
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02418520
Sponsor's protocol ID
KSAUHS2015
Acronym
Miswak
Status last verified
Aug 2021
First submitted
9 Apr 2015
Last updated
25 Aug 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Rifaey N, AlAdwani M, Karched M, Baskaradoss JK. A clinical investigation into the efficacy of miswak chewing sticks as an oral hygiene aid: A crossover randomized trial. Int J Dent Hyg. 2021 May;19(2):223-230. doi: 10.1111/idh.12484. Epub 2020 Dec 20.

    PubMed 33258168
  • Aksit Bicak D, Akyuz S, Kiratli B, Usta M, Urganci N, Alev B, Yarat A, Sahin F. The investigation of Helicobacter pylori in the dental biofilm and saliva samples of children with dyspeptic complaints. BMC Oral Health. 2017 Mar 21;17(1):67. doi: 10.1186/s12903-017-0361-x.

    PubMed 28327128
  • Contractor QQ, Tahir MY, Naseem S, Ahmad S. Helicobacter pylori in the dental plaque of healthy Saudis. Saudi J Gastroenterol. 1998 Jan;4(1):13-6.

    PubMed 19864780

Questions about this trial

What is this clinical trial studying?

A study testing Miswak in people with Caries and Periodontitis, run by Kuwait University at 1 site in Kuwait.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Kuwait. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The main outcome measure would be the change over time of the microbiologic data, specifically the H.Pylori counts within both groups. (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02418520, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in